Aetion is a leading science-driven technology company focused on utilizing real-world evidence to enhance healthcare decision-making. Through its innovative applications powered by the Aetion Evidence Platform, the company evaluates the safety, effectiveness, and value of medications, ultimately aiming to improve outcomes for patients, healthcare professionals, and clients. Aetion collaborates with top biopharma companies and is supported by prominent venture capital firms to advance medical research and expand its product offerings. Recently, Aetion has entered into an agreement to be acquired by Datavant, a prominent health data platform company, further solidifying its position in the healthcare analytics landscape.